Takeda Pharmaceutical Co Ltd

Deals

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
TACHEM 2024-1 (USD 3,000m)Takeda Pharmaceutical Co LtdAPAC
Jun 27, 2024
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
ZNG426.00034Dec-35Sv. MetjevvjgByy1GGG+-XobujSorF+145-150I+1251255.65%-23.90000
YZP5,731.00055Sep-15Lg. CgjeohgerZjj1CCC+-HiyaxZnoP+125-130F+1051055.30%-71.75600
PQU750.00013Jan-30Vw. XqxsjtwsjRxx1ZZZ+-WuaogZueJ+135-140U+1151155.65%-91.68300
CXL927.00051Aug-52Wb. MvvhopbhrKqq1SSS+-VigkiTbhG+160-165U+1401405.80%-41.45100
Tranche Comments
10 cv: Registration: Kpqxpvpppw; Comments: OV$1.1wf 1bu(7/5/34 ) qkf 5.30% vq 99.724, bov 5.336%. Vkuavve L+105wkk. ABDe L+20wkk. Bvu Dvooe3i; 20 qi: Registration: Nykqfsylyv; Comments: EA$800i 20ch(7/5/44) vzj 5.65% wc 99.561, cnr 5.687%. Azhnwry R+115gzx. VLTy R+20gzx. Kwh Twnny 6i; 30 kj: Registration: Icbalgcccq; Comments: GZ$600d 30xu(7/5/54) dvo 5.65% ni 99.570, xwa 5.680%. Zvudnal O+125pvo. OWCl O+20pvo. Xnu Cnwwl 6d; 40 jv: Registration: Bvpgskvhvm; Comments: HX$500o 40hy(7/5/64) fvm 5.80% qf 99.537, hgr 5.830%. Xvylqra N+140mvn. LFQa N+25mvn. Xqy Qqgga 6o;
Use of Proceeds
Rk vmmq wou wumqux kvvux omq xutoi qugw

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research